Drug News

All Eyes on Roche’s Competing Ophthalmology Drugs

March 6, 2011   ·   0 Comments

for AMD. In the US, all eyes are on the NIH’s National Eye Institute. Of the two drugs, only Lucentis was approved by the FDA to treat AMD, but many docs believe Avastin is equally effective and because of huge differences in price – $ 30-plus an
Moreover Technologies – Search results for… drugs – 30 of 905 returned

Purchasing Managed Care Services for Alcohol and Other Drug Treatment – Essential Elements and Policy Issues

Price:





By


Readers Comments (0)


You must be logged in to post a comment.